Prevalence of idiopathic pulmonary fibrosis in Japan and the US: a claims-based retrospective study

Y. Kondoh (Aichi, Japan), T. Suda (Shizuoka, Japan), Y. Hongo (Tokyo, Japan), M. Yoshida (Tokyo, Japan), S. Hiroi (Tokyo, Japan), K. Iwasaki (Tokyo, Japan), T. Takeshima (Tokyo, Japan), S. Homma (Tokyo, Japan)

Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session: Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session type: E-poster session
Number: 1844
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Kondoh (Aichi, Japan), T. Suda (Shizuoka, Japan), Y. Hongo (Tokyo, Japan), M. Yoshida (Tokyo, Japan), S. Hiroi (Tokyo, Japan), K. Iwasaki (Tokyo, Japan), T. Takeshima (Tokyo, Japan), S. Homma (Tokyo, Japan). Prevalence of idiopathic pulmonary fibrosis in Japan and the US: a claims-based retrospective study. 1844

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019

Economic evaluation of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A retrospective, case-controlled, cost of illness study
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010


Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019
Year: 2019



Management of idiopathic pulmonary fibrosis in France: A survey of 1,456 pulmonologists
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012


Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Tobacco smoking and risk for idiopathic pulmonary fibrosis: a prospective cohort study in UK Biobank
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017

Post-marketing surveillance of pirfenidone for idiopathic pulmonary fibrosis in Japan: Interim analysis of 973 patients
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020

Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014


A large-scale population-based cohort study of idiopathic interstitial pneumonia in Japan
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015



Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017



Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013
Source: Eur Respir J, 51 (1) 1701603; 10.1183/13993003.01603-2017
Year: 2018



Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis. A study of 404 pulmonologists from 57 countries.
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017

PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study
Source: Eur Respir J, 54 (1) 1900103; 10.1183/13993003.00103-2019
Year: 2019